Vimarsana
Biggest News Aggregation in the World

Menashe Levy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Menashe Levy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Menashe Levy Today - Breaking & Trending Today

Cabinet approves Maoz's return to role overseeing school programing, Jewish identity - Vimarsana News

Cabinet approves Maoz's return to role overseeing school programing, Jewish identity

Far-right MK seeks to increase 'transparency' for parents on vendor-provided curricula; education minister says he won't permit 'extremism' or changes to his ministry's powers

Head-To-Head Analysis: Gamida Cell (NASDAQ:GMDA) vs. Codiak BioSciences (NASDAQ:CDAK) - Vimarsana News

Head-To-Head Analysis: Gamida Cell (NASDAQ:GMDA) vs. Codiak BioSciences (NASDAQ:CDAK)

Gamida Cell (NASDAQ:GMDA – Get Rating) and Codiak BioSciences (NASDAQ:CDAK – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership and profitability. Insider and Institutional Ownership 53.4% of Gamida Cell shares […]

Reviewing Gamida Cell (NASDAQ:GMDA) and Entera Bio (NASDAQ:ENTX) - Vimarsana News

Reviewing Gamida Cell (NASDAQ:GMDA) and Entera Bio (NASDAQ:ENTX)

Gamida Cell (NASDAQ:GMDA – Get Rating) and Entera Bio (NASDAQ:ENTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations. Profitability This table compares Gamida Cell and Entera Bio’s […]

Q1 2022 EPS Estimates for Gamida Cell Ltd. Decreased by Oppenheimer (NASDAQ:GMDA) - Vimarsana News

Q1 2022 EPS Estimates for Gamida Cell Ltd. Decreased by Oppenheimer (NASDAQ:GMDA)

Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) – Equities researchers at Oppenheimer lowered their Q1 2022 EPS estimates for Gamida Cell in a report issued on Tuesday, March 15th. Oppenheimer analyst M. Breidenbach now expects that the company will post earnings of ($0.38) per share for the quarter, down from their prior estimate of ($0.32). […]

Gamida Cell (NASDAQ:GMDA) Issues Quarterly Earnings Results, Misses Estimates By $0.08 EPS - Vimarsana News

Gamida Cell (NASDAQ:GMDA) Issues Quarterly Earnings Results, Misses Estimates By $0.08 EPS

Gamida Cell (NASDAQ:GMDA – Get Rating) posted its quarterly earnings results on Tuesday. The company reported ($0.52) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.44) by ($0.08), Fidelity Earnings reports. During the same quarter in the prior year, the company posted ($0.68) EPS. Shares of GMDA stock traded up […]